Bayer's US Supreme Court victory lifts DAX index

Key Facts

1Bayer won a major lawsuit in the US Supreme Court, overturning a jury award for a Missouri man who claimed Roundup causes cancer, saving the company billions of dollars.

In a major legal development removing a key overhang for major German corporates, Bayer (BAYRY) announced it won a US Supreme Court case over its Roundup herbicide. The court overturned a previous jury award to a Missouri man who claimed the product causes cancer, saving the company billions of dollars, according to reports. Bayer shares surged on Thursday June 25, pushing the DAX index toward a critical level.

BAYRY closed at $13.16 on June 25, up from an intraday low of $11.27, per market data. Rheinmetall (RNMBY) ended at $214.05 while Volkswagen (VWAGY) settled at $8.87. The victory strengthens Bayer's legal position against thousands of similar lawsuits, potentially capping future damages.

Looking ahead, investors will watch for broader market reactions and implications for the chemicals sector. Markets also await a speech by ECB President Christine Lagarde later today and past comments from Fed's Christopher Waller, which may steer European indices and currencies. BAYRY at $13.16 (June 25 close) may test resistance at $13.40 if positive momentum continues.